ACCESS AND PRODUCTIVITY OUTCOMES WITH RADIOLOGY TECHNOLOGY IN WESTERN SYDNEY Outcomes despite insufficient indexation, Government funding and workforce shortages
With
Leon Berkovich, CEO
GE HealthCare Australia and New Zealand
Dr Mansoor Parker
Diagnostic & Interventional Radiologist & Founding Partner,
Quantum Radiology, Sydney
SEGMENT
Filmed in Sydney | November 2025
In Western Sydney, there is currently significant growth accompanied by a notable need for cardiovascular support due to the prevalence of related diseases. It is estimated that the population in this area will reach 6 million by 2041.
With this population growth, there is also a pressing shortage of healthcare professionals in Australia, particularly in the field of radiology, where there are not enough radiographers, sonographers, MRI technicians, and nuclear medicine technicians.
Previously, conducting complex imaging studies required the expertise of highly experienced technicians. Nonetheless, advancements in technology have enabled businesses to invest in new CT scanning technologies, from organisations such as GE HealthCare, making available the first of its kind in the Southern Hemisphere.
According to Dr. Mansoor Parker, a Diagnostic and Interventional Radiologist in Western Sydney and Founder of Quantum Radiology, the technology can produce consistent, high-quality studies that do not solely rely on the skill of the technician.
Dr. Parker spoke to Australian Health Journal about the unique nature of Western Sydney as a cultural melting pot that has historically suffered from a lack of high-quality healthcare. His motivation for establishing radiology practices in this area stemmed from his own experiences of limited access to imaging services, especially MRI and interventional procedures.
He notes that the challenges faced by the population often go beyond mere accessibility, including language barriers and the need for culturally sensitive care that respects privacy while delivering high standards of healthcare.
According to Leon Berkovich, CEO of GE HealthCare Australia & New Zealand, GE HealthCare has excelled in obtaining AI patents within the imaging sector, demonstrating significant technological adoption in Australia—a mature market where clinicians are eager to integrate the latest technology across all areas. The growth in Western Sydney continues to highlight the urgent need for cardiovascular imaging services, and demographic projections indicate robust population increases.
Source: Adapted from transcript
-
Report gives insights to clinical trial activity in Australia
Established in 2024, Bellberry is a Adelaide-based national, not-for-profit organisation that provides streamlined scientific and ethical reviews of human research. It is the 2025 winner of the Championing Health Award in the Telstra Best of Business Awards.
Australian Health Journal spoke with Bellberry Limited CEO, Kylie Sproston on the organisation and the findings in activity documented in the Clinical Trial Activity Report (CTAR) 2024.
-
New research papers show productivity gains and gaps
Commissioner Catherine De Fontenay talks about the Productivity Commission’s new approach to analysing health productivity, shifting the perspective from the unit measurement of individuals using the health system to the actual improvement of health. This has shown Australia’s health treatment productivity is improving, but identifies gaps in preventative health measures and duplication, where digital technology needs to be more effectively used.
-
Research funded to investigate early-onset bowel cancer progression
Bowel Cancer Australia recently announced a team led by Professor Michael Samuel as the successful applicant for a three-year $600k early-onset bowel cancer research project through the 2023 round of Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS).
